Chutes & Ladders—Merck loses another top exec, this time to Moderna
Chutes & Ladders—Merck loses another top exec, this time to [...]
With the makings of a hub, NYC primed to be life sciences leader
With the makings of a hub, NYC primed to be [...]
UPDATE: Sio Gene Therapies warns of ‘significant’ layoffs after ditching final two assets
UPDATE: Sio Gene Therapies warns of ‘significant’ layoffs after ditching [...]
Pfizer’s phase 3 DMD gene therapy test resumes after FDA hold, but decision on advanced patients still pending
Pfizer’s phase 3 DMD gene therapy test resumes after FDA [...]
Future shaky at Solid Bio as it shaves off 35% of workforce, chief operating officer plans exit
Future shaky at Solid Bio as it shaves off 35% [...]
BridgeBio strategy head departs amid company’s second round of layoffs this year
BridgeBio strategy head departs amid company’s second round of layoffs [...]
2 become 1: Caladrius and Cend merge into tumor-focused Lisata Therapeutics
2 become 1: Caladrius and Cend merge into tumor-focused Lisata [...]
Amgen opts to DARP-out after seeing early data from $50M Molecular Partners collab
Amgen opts to DARP-out after seeing early data from $50M [...]
Editas sees clinical promise with new FDA pediatric disease tag for another blood disorder
Editas sees clinical promise with new FDA pediatric disease tag [...]
Pfizer-Valneva’s Lyme disease vaccine performs even better in children
Pfizer-Valneva’s Lyme disease vaccine performs even better in children aarmstrong [...]